Positive STAT5 Protein and Locus Amplification Status Predicts Recurrence after Radical Prostatectomy to Assist Clinical Precision Management of Prostate Cancer.
Bassem R HaddadAndrew EricksonVindhya UdhanePeter S LaVioletteJanice D RoneMarkku A KallajokiWilliam A SeeAntti Sakari RannikkoTuomas MirttiMarja T NevalainenPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2019)
Our results highlight potential for a novel precision medicine concept based on a pivotal role of STAT5 status in improving selection of prostate cancer patients who are candidates for early adjuvant interventions to reduce the risk of recurrence.